Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00770120 · FLOW

Participant flow

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2020-03-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Daily oral Everolimus 10 mg/day everolimus
    id
    FG000
    title
    Everolimus
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        31
      type
      Progression
    2. reasons
      1. group Id
        FG000
        num Subjects
        11
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        11
      type
      Not Protocol Specified
    4. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Ineligible
    7. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Never Received Treatment/Not Analyzable
    8. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Reason under Review
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        61
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        60
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      type
      Not Analyzable
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    5. achievements
      1. group Id
        FG000
        num Subjects
        61
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Daily oral Everolimus 10 mg/day everolimus
    id
    FG000
    title
    Everolimus
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        31
      type
      Progression
    2. reasons
      1. group Id
        FG000
        num Subjects
        11
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        11
      type
      Not Protocol Specified
    4. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Ineligible
    7. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Never Received Treatment/Not Analyzable
    8. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Reason under Review
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        61
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        60
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      type
      Not Analyzable
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    5. achievements
      1. group Id
        FG000
        num Subjects
        61
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice